| Suppression of human glioma xenografts with second-generation IL13R-specific chimeric antigen receptor–modified T cells S Kong, S Sengupta, B Tyler, AJ Bais, Q Ma, S Doucette, J Zhou, A Sahin, ... Clinical Cancer Research 18 (21), 5949-5960, 2012 | 178 | 2012 |
| Significance of interleukin-13 receptor alpha 2–targeted glioblastoma therapy B Thaci, CE Brown, E Binello, K Werbaneth, P Sampath, S Sengupta Neuro-oncology 16 (10), 1304-1312, 2014 | 164 | 2014 |
| Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumors DA Wainwright, S Sengupta, Y Han, MS Lesniak Neuro-oncology 13 (12), 1308-1323, 2011 | 129 | 2011 |
| Impact of temozolomide on immune response during malignant glioma chemotherapy S Sengupta, J Marrinan, C Frishman, P Sampath Journal of Immunology Research 2012, 2012 | 125 | 2012 |
| Mechanisms of immune evasion by gliomas CE Rolle, S Sengupta, MS Lesniak Glioma: Immunotherapeutic Approaches, 53-76, 2012 | 116 | 2012 |
| Mesenchymal stem cells modified with a single-chain antibody against EGFRvIII successfully inhibit the growth of human xenograft malignant glioma IV Balyasnikova, SD Ferguson, S Sengupta, Y Han, MS Lesniak PloS one 5 (3), e9750, 2010 | 95 | 2010 |
| Bone marrow mesenchymal stem cells loaded with an oncolytic adenovirus suppress the anti-adenoviral immune response in the cotton rat model AU Ahmed, CE Rolle, MA Tyler, Y Han, S Sengupta, DA Wainwright, ... Molecular Therapy 18 (10), 1846-1856, 2010 | 84 | 2010 |
| The presence of IL-17A and T helper 17 cells in experimental mouse brain tumors and human glioma DA Wainwright, S Sengupta, Y Han, IV Ulasov, MS Lesniak PloS one 5 (10), e15390, 2010 | 66 | 2010 |
| Short hairpin RNA-mediated fibronectin knockdown delays tumor growth in a mouse glioma model S Sengupta, S Nandi, ES Hindi, DA Wainwright, Y Han, MS Lesniak Neoplasia 12 (10), 837-847, 2010 | 63 | 2010 |
| Challenges in clinical design of immunotherapy trials for malignant glioma CE Rolle, S Sengupta, MS Lesniak Neurosurgery Clinics 21 (1), 201-214, 2010 | 56 | 2010 |
| Interleukin-13 receptor alpha 2-targeted glioblastoma immunotherapy S Sengupta, B Thaci, AC Crawford, P Sampath BioMed Research International 2014, 2014 | 51 | 2014 |
| Glycogen synthase kinase 3 inhibition lowers PD-1 expression, promotes long-term survival and memory generation in antigen-specific CAR-T cells S Sengupta, SC Katz, S Sengupta, P Sampath Cancer Letters 433, 131-139, 2018 | 50 | 2018 |
| Unrestrained glycogen synthase kinase-3β activity leads to activated T cell death and can be inhibited by natural adjuvant S Sengupta, P Jayaraman, PM Chilton, CR Casella, TC Mitchell The Journal of Immunology 178 (10), 6083-6091, 2007 | 32 | 2007 |
| Chimeric antigen receptors for treatment of glioblastoma: a practical review of challenges and ways to overcome them S Sengupta, G Mao, ZS Gokaslan, P Sampath Cancer gene therapy 24 (3), 121-129, 2017 | 28 | 2017 |
| Development of a function-blocking antibody against fibulin-3 as a targeted reagent for glioblastoma MS Nandhu, P Behera, V Bhaskaran, SL Longo, LM Barrera-Arenas, ... Clinical Cancer Research 24 (4), 821-833, 2018 | 27 | 2018 |
| Enhanced transduction and replication of RGD-fiber modified adenovirus in primary T cells S Sengupta, IV Ulasov, B Thaci, AU Ahmed, MS Lesniak PLoS One 6 (3), e18091, 2011 | 23 | 2011 |
| Adjuvant-induced survival signaling in clonally expanded T cells is associated with transient increases in pAkt levels and sustained uptake of glucose S Sengupta, PM Chilton, TC Mitchell Immunobiology 210 (9), 647-659, 2005 | 14 | 2005 |
| Methods and compositions for treating cancer P Sampath, S Sengupta, RP Junghans US Patent 9,650,428, 2017 | 8 | 2017 |
| Updates on chimeric antigen receptor-mediated glioblastoma immunotherapy G Mao, P Sampath Rhode Island Medical Journal 100 (6), 39, 2017 | 5 | 2017 |
| Inhibition of GSK3beta leads to increased survival, proliferation and memory phenotype generation of GBM-specific CAR T cells (VAC5P. 1125) S Sengupta, P Guha, S Katz, P Sampath The Journal of Immunology 194 (1_Supplement), 73.10-73.10, 2015 | 4 | 2015 |
Ilya UlasovSechenov First Moscow State Medical University, Moscow, RussiaDirección de correo verificada de staff.sechenov.ru
